Identification of antimicrobial peptides from ancient gut microbiomes

S Sizhe Chen Y Yue Yuan Y Yun Wang Y Ye Peng H Hein Min Tun Z Zhimin Jiang (Guangxi Key Laboratory of Drug Discovery and Optimization, School of Pharmacy) Y YingLei Miao S Sunjae Lee (Life Sciences and Medical Convergence Gwangju Institute of Science and Technology) X Xiaole Yin X Xiaotao Shen O Orlando DeLeon E Eugene B. Chang (Department of Medicine, The University of Chicago, Chicago, IL, USA.) F Francis Ka Leung Chan Y Yang Sun S Siew Chien Ng Q Qi Su

Abstract

Abstract Fecal coprolites preserve ancient microbiomes and are a potential source of extinct but highly efficacious antimicrobial peptides (AMPs). Here, we develop AMPLiT (AMP Lightweight Identification Tool), an efficient tool deployable to portable hardware for AMP screening in metagenomic datasets. AMPLiT demonstrates AUPRC performances of 0.9486 ± 0.0003 and reasonable overall training time of 3200 ± 53 s. By computationally utilizing AMPLiT, we analyze seven ancient human coprolite metagenomes, identifying 160 AMP candidates. Of 40 representative peptides synthesized, 36 (90%) peptides demonstrate measurable antimicrobial activity at 100 μM or less in vitro. Strikingly, approximately two-thirds of these peptides are sourced from Segatella copri , a dominant ancient gut commensal that is conspicuously underrepresented in modern populations, particularly those with Westernized lifestyles. Representative S. copri -derived AMPs exhibit disruptions against membranes of pathogenic bacteria, coupled with low cytotoxicity and hemolytic risk. In vivo, lead peptides demonstrate potent antibacterial and wound-healing efficacy comparable to traditional antibiotics, especially in combating gram-positive pathogens. Our findings highlight the ancient gut microbiomes as sources of novel AMPs, offering valuable insights into the historical role of S. copri in human health and its decline in contemporary populations.

Article Details

Volume / Issue Vol. 17, Issue 1
Published January 14, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (16)

S

Sizhe Chen

Y

Yue Yuan

Y

Yun Wang

Y

Ye Peng

H

Hein Min Tun

Z

Zhimin Jiang

Guangxi Key Laboratory of Drug Discovery and Optimization, School of Pharmacy

Y

YingLei Miao

S

Sunjae Lee

Life Sciences and Medical Convergence Gwangju Institute of Science and Technology

X

Xiaole Yin

X

Xiaotao Shen

O

Orlando DeLeon

E

Eugene B. Chang

Department of Medicine, The University of Chicago, Chicago, IL, USA.

F

Francis Ka Leung Chan

Y

Yang Sun

S

Siew Chien Ng

Q

Qi Su